Glaukos (GKOS) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseZacks Investment Research • 04/23/25
Glaukos to Present Multiple Scientific Abstracts at the 2025 American Society of Cataract and Refractive Surgery (ASCRS) Annual MeetingBusiness Wire • 04/23/25
Glaukos to Release First Quarter 2025 Financial Results after Market Close on April 30Business Wire • 04/09/25
3 Stocks to Watch in the Evolving Cell-Based Ophthalmic Therapy SpaceZacks Investment Research • 03/31/25
RadiusXR and Glaukos Corporation Announce a New Collaboration With Topcon Healthcare, Inc. and the Launch of Inspire®: A Next-Generation Visual Field SolutionBusiness Wire • 03/11/25
GKOS Crashes Almost 25% After Q4 Earnings: How to Play the Stock?Zacks Investment Research • 02/28/25
FDA Sets Decision Date For Glaukos' Keratoconus Treatment Without The Need Of SurgeryBenzinga • 02/24/25
Glaukos Delivers Mixed Q4 Results, Analyst Sees Growing Investor Interest During TransitionBenzinga • 02/21/25
GKOS Stock Falls Despite Q4 Earnings & Revenue Beat, Margins DeclineZacks Investment Research • 02/21/25
What Analyst Projections for Key Metrics Reveal About Glaukos (GKOS) Q4 EarningsZacks Investment Research • 02/17/25
Glaukos to Release Fourth Quarter and Full Year 2024 Financial Results after Market Close on February 20Business Wire • 01/23/25
Glaukos Announces Positive Clinical Updates for its iDose® Sustained-Release Procedural Pharmaceutical PlatformBusiness Wire • 01/14/25